Kang Le Pharmaceutical Company

"Kangle Medicine Welcomes You"!
Our company promises: Honesty, genuine products at reasonable prices, selling conscientious medicines, cash on delivery,
Beijing Kangle Medicine
Contact person: Manager Bai (Ms.)
Contact number QQ
India Gleevec Imatinib/box
For sale India Gleevec Generic name: Imatinib mesylate Trade name: Gleevec?(?)
[Indications] Use For the treatment of patients with chronic myelogenous leukemia (M) in the blast phase, accelerated phase or chronic phase after h treatment failure. For the treatment of patients with unresectable and/or metastatic malignant gastrointestinal stromal tumors.
United States The Food and Drug Administration has approved Novartis' drug Gleevec (imatinib mesylate) to treat a rare, life-threatening disease for which there are currently few treatments. This new indication for Gleevec is that it cannot be removed. of.
Metastatic and/or recurrent dermatofibrosarcoma protuberans, refractory Philadelphia chromosome-positive acute lymphoblastic leukemia, myeloid dysplasia associated with platelet-derived growth factor receptor gene arrangement Disease,
/h fusion gene positive or negative hypereosinophilic syndrome or chronic eosinophilic leukemia patients, systemic mastocytosis without D gene mutation or unknown gene mutation, this is< br/> The first approval of a drug for simultaneous use in a new indication.
[Specifications]
[Usage and Dosage] Starting dose: Treatment should be started by a physician who is experienced in the treatment of chronic myelogenous leukemia or Carry out. This product should be taken orally. It should be taken with a meal and a large glass of water. Usually once a day. Children and adolescents can take it once a day or in two divided doses (morning and evening). Patients who cannot swallow (Children). The medicine can be dispersed in water or apple juice. It is recommended that pregnant and lactating women avoid contact with the skin or eyes or inhalation of the medicine when opening (see Pregnant and Lactating Women). Wash hands immediately after touching opened products.
[Storage] Store below ℃
[Packaging] Aluminum granules per box [Executive Standard] Imported Drug Registration Standards
Introduction to Gleevec in India
Imatinib (the active ingredient of Gleevec from India) competitively inhibits the binding site with thymidine kinase receptors, blocks phosphorylation, thereby inhibiting signal transduction, and can inhibit mutations related to kinase activity
(causing receptor activation) and wild-type. Its target sites are mainly (B) protein, protein and platelet-derived growth factor (D) receptor. Imatinib (active ingredient of Gleevec from India) can pass < br/> Gain-of-function mutations cause stem cell factor-independent activation to reduce kinase phosphorylation from cell lines. When the concentration reaches m/, kinase phosphorylation can be completely inhibited